Ancora Advisors, LLC Johnson & Johnson Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ancora Advisors, LLC holds 269,566 shares of JNJ stock, worth $41.2 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

269,566

Previous 283,194 4.81%

Holding current value

$41.2 Million

Previous $41.4 Million 5.54%

% of portfolio

1.08%

Previous 1.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $1.98 Million - $2.28 Million	-13,628 Reduced 4.81%	269,566 $43.7 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $286,883 - $313,508	1,987 Added 0.71%	283,194 $41.4 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $2.9 Million - $3.05 Million	-18,715 Reduced 6.24%	281,207 $44.5 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $921,065 - $1.01 Million	-6,326 Reduced 2.07%	299,922 $47 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $1.27 Million - $1.42 Million	-8,153 Reduced 2.59%	306,248 $47.7 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $645,800 - $695,004	4,184 Added 1.35%	314,401 $52 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $900,258 - $1.07 Million	5,960 Added 1.96%	310,217 $48.1 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $4.96 Million - $5.57 Million	30,959 Added 11.33%	304,257 $53.7 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $609,504 - $678,226	3,778 Added 1.4%	273,298 $44.6 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $652,072 - $721,160	3,877 Added 1.46%	269,520 $47.8 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $312,642 - $355,049	1,977 Added 0.75%	265,643 $47.1 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $1.47 Million - $1.66 Million	-9,271 Reduced 3.4%	263,666 $43.3 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $870,557 - $965,914	5,583 Added 2.09%	272,937 $46.7 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $1.48 Million - $1.64 Million	9,162 Added 3.55%	267,354 $43.2 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $872,993 - $936,437	-5,474 Reduced 2.08%	258,192 $42.5 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $971,994 - $1.08 Million	6,350 Added 2.47%	263,666 $43.3 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $361,284 - $414,696	2,635 Added 1.03%	257,316 $40.5 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $1.11 Million - $1.21 Million	7,877 Added 3.19%	254,681 $37.9 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $381,535 - $460,620	2,962 Added 1.21%	246,804 $34.7 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $1.67 Million - $2.31 Million	15,033 Added 6.57%	243,842 $32 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $4.52 Million - $5.19 Million	35,463 Added 18.34%	228,809 $33.4 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $1.29 Million - $1.44 Million	10,155 Added 5.54%	193,346 $25 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $702,177 - $772,260	5,354 Added 3.01%	183,191 $25.5 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $889,343 - $988,874	7,074 Added 4.14%	177,837 $24.9 Million
Q4 2018 Feb 15, 2019	BUY	$122.84 - $147.84 $665,424 - $800,849	5,417 Added 3.28%	170,763 $22 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $3.7 Million - $4.35 Million	30,418 Added 22.54%	165,346 $22.8 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $400,587 - $442,054	3,355 Added 2.55%	134,928 $16.4 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $2.42 Million - $2.87 Million	19,371 Added 17.26%	131,573 $16.9 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $383,556 - $419,801	2,923 Added 2.67%	112,202 $15.7 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $14.1 Million - $14.8 Million	109,279	109,279 $14.2 Million

Others Institutions Holding JNJ

# of Institutions

4,309

Shares Held

1.68B

Call Options Held

17.7M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Johnson & Johnson Transaction History